Ampio pharmaceuticals issues letter to stockholders

Englewood, colo. , aug. 3, 2022 /prnewswire/ -- ampio pharmaceuticals, inc. (nyse american: ampe), today released the following letter to stockholders from its chairman, kevin buchi and chief executive officer, mike martino.
AMPE Ratings Summary
AMPE Quant Ranking